Karralli Rusol, Tipton Joyce, Dumitru Doina, Scholz Lisa, Masilamani Santhi
Rusol Karralli, Pharm.D., M.S., is Manager, 340B Education and Compliance Support, 340B Prime Vendor Program, Apexus, Irving, TX. At the time of writing Dr. Karralli was Postgraduate Year 2 Health-System Pharmacy Administration Resident, Memorial Hermann Health System, Houston, TX. Joyce Tipton, B.S.Pharm., M.B.A., FASHP, is Director of Pharmacy and Respiratory Services, Memorial Hermann Memorial City Medical Center, Houston. Doina Dumitru, Pharm.D., M.B.A., FASHP, is Director of Pharmacy, Memorial Hermann The Woodlands, The Woodlands, TX. Lisa Scholz, Pharm.D., M.B.A., is Chief Operating Officer/Chief Pharmacy Officer, Safety Net Hospitals for Pharmaceutical Access, Washington, DC. Santhi Masilamani, Pharm.D., M.B.A., CDE, is Director, Ambulatory Care Advanced Pharmacy Practice Experiences, and Clinical Assistant Professor, University of Houston College of Pharmacy.
Am J Health Syst Pharm. 2015 Sep 1;72(17):1489-95. doi: 10.2146/ajhp140567.
An electronic tool to support hospital organizations in monitoring and addressing financial and compliance challenges related to participation in the 340B Drug Pricing Program is described.
In recent years there has been heightened congressional and regulatory scrutiny of the federal 340B program, which provides discounted drug prices on Medicaid-covered drugs to safety net hospitals and other 340B-eligible healthcare organizations, or "covered entities." Historically, the 340B program has lacked a metrics-driven reporting framework to help covered entities capture the value of 340B program involvement, community benefits provided to underserved populations, and costs associated with compliance with 340B eligibility requirements. As part of an initiative by a large health system to optimize its 340B program utilization and regulatory compliance efforts, a team of pharmacists led the development of an electronic dashboard tool to help monitor 340B program activities at the system's 340B-eligible facilities. After soliciting input from an array of internal and external 340B program stakeholders, the team designed the dashboard and associated data-entry tools to facilitate the capture and analysis of 340B program-related data in four domains: cost savings and revenue, program maintenance costs, community benefits, and compliance.
A large health system enhanced its ability to evaluate and monitor 340B program-related activities through the use of a dashboard tool capturing key metrics on cost savings achieved, maintenance costs, and other aspects of program involvement.
介绍一种电子工具，用于支持医院组织监测和应对与参与340B药品定价计划相关的财务和合规挑战。
近年来，国会和监管机构对联邦340B计划的审查力度加大，该计划为安全网医院和其他符合340B资格的医疗保健组织（即“受保实体”）提供医疗补助覆盖药品的折扣价格。从历史上看，340B计划缺乏一个以指标为驱动的报告框架，以帮助受保实体获取参与340B计划的价值、为服务不足人群提供的社区福利以及与遵守340B资格要求相关的成本。作为一个大型医疗系统优化其340B计划利用和监管合规工作的一项举措的一部分，一组药剂师牵头开发了一个电子仪表盘工具，以帮助监测该系统符合340B资格的设施的340B计划活动。在征求了一系列内部和外部340B计划利益相关者的意见后，该团队设计了仪表盘和相关的数据输入工具，以促进在四个领域收集和分析与340B计划相关的数据：成本节约和收入、计划维护成本、社区福利和合规情况。
一个大型医疗系统通过使用一个仪表盘工具增强了其评估和监测与340B计划相关活动的能力，该工具可获取有关实现的成本节约、维护成本以及计划参与其他方面的关键指标。
